Genix Pharmaceuticals Corp

NEW
OTCPK:GENPF (Canada)  
$ 0.015 (0%) 08:09 PM EST
At Loss
Market Cap:
$ 647.00K
Enterprise V:
$ 1.40M
Volume:
0
Avg Vol (2M):
8.00K
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
8.00K

Business Description

Description
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
0.01
Equity-to-Asset
-42.03
Debt-to-Equity
-0.73
Debt-to-EBITDA
-10.28
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
27.9
3-Year EPS without NRI Growth Rate
19.3
3-Year FCF Growth Rate
20.6

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
100
9-Day RSI
100
14-Day RSI
99.42
6-1 Month Momentum %
-53
12-1 Month Momentum %
2.17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.02
Quick Ratio
0.02
Cash Ratio
0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-1.1
Shareholder Yield %
-26.85

Profitability Rank

Name Current Vs Industry Vs History
ROA %
-663.51
ROIC %
-9.91
3-Year ROIIC %
-24.77
Years of Profitability over Past 10-Year
1

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-18.72
EV-to-EBITDA
-18.9
EV-to-FCF
-21.8
Earnings Yield (Greenblatt) %
-5.34
FCF Yield %
-9.91

Financials

GENPF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:GENPF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Genix Pharmaceuticals Corp Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.007
Beta -0.0477
3-Year Sharpe Ratio -0.07
3-Year Sortino Ratio -0.1
Volatility % 119.04
14-Day RSI 99.42
14-Day ATR ($) 0.000062
20-Day SMA ($) 0.0143
12-1 Month Momentum % 2.17
52-Week Range ($) 0.0138 - 0.03573
Shares Outstanding (Mil) 61.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genix Pharmaceuticals Corp Filings

Filing Date Document Date Form
No Filing Data

Genix Pharmaceuticals Corp Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Genix Pharmaceuticals Corp Frequently Asked Questions

What is Genix Pharmaceuticals Corp(GENPF)'s stock price today?
The current price of GENPF is $0.02. The 52 week high of GENPF is $0.04 and 52 week low is $0.01.
When is next earnings date of Genix Pharmaceuticals Corp(GENPF)?
The next earnings date of Genix Pharmaceuticals Corp(GENPF) is .
Does Genix Pharmaceuticals Corp(GENPF) pay dividends? If so, how much?
Genix Pharmaceuticals Corp(GENPF) does not pay dividend.

Guru Commentaries on OTCPK:GENPF

No articles.

Press Release

Subject Date
No Press Release

Articles on Genix Pharmaceuticals Corp

No articles.

Headlines

See More
  • 1
No news.
  • 1